小児科の経験と,腎不全の子どもおよび青少年に対する治療勧告の関係
1Division of Pediatric Nephrology, Department of Pediatrics, Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, MD, USA. sfurth@jhmi.edu
JAMA
|March 7, 2001
まとめ
小児腎臓科医は,成人腎臓科医よりも,腎不全の子供に腹腔内透析を推奨する可能性が60%高い. これは,臨床医の専門性が,小児末期腎疾患の治療決定にどのように影響するかを強調しています.
科学分野:
- ネフロロジーはネフロロジーを用います.
- 小児腎臓病理学について
- 透析治療について
背景:
- 腎不全の子どもは,成人のサブスペシャリストからケアを受けることが多い.
- 腹腔内透析は,大人の場合とは異なり,小児の場合は好ましい透析法です.
- 既存のデータは,小児患者の間での腹膜透析の使用の変動を示していますが,臨床医の経験の影響は不明です.
研究 の 目的:
- 腎臓科医の小児経験が小児腎不全患者の治療推奨に影響を与えているかどうかを判断する.
- 子どもに対する透析方式の選択に対するサブスペシャリティトレーニングの影響を評価する.
主な方法:
- 参加者1人につき10件のケースヴィニエットを使用して,横断調査を実施しました.
- ヴィニエットは,治療勧告を評価するために,ランダム化された患者の特徴を提示した.
- 316人の成人および小児腎臓科医の全国的なランダムサンプルが調査に応じた.
主要な成果:
- 小児腎臓科医は,同一の小児患者の場合,血液透析よりも腹膜透析を推奨する可能性が60%高かった.
- この増加した可能性は,患者の特徴,臨床医の訓練,診療環境,または長年の実務経験に関係なく持続しました.
- 腹膜透析を推奨する確率比は,小児専門医の1.61 (95%CI,1.35-1.92) でした.
結論:
- 臨床医の専門性は,小児末期腎疾患の治療推奨に大きく影響します.
- 大人のサブスペシャリストへの紹介は,子供の異なる治療選択とケアプロセスにつながる可能性があります.
- 小児専門腎臓科医による治療の確保は,小児における最適な透析方式の選択に不可欠です.
関連する概念動画
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...